Will you consider adding an AR targeted agent to ADT for a patient thought to have isolated pelvic nodal recurrence of prostate CA if next generation imaging reveals additional non-regional disease not seen on conventional imaging?  

Patient previously had prostatectomy and salvage RT

Answer from: Medical Oncologist at Academic Institution